Alginatol^® (Suppositories) Instructions for Use

Marketing Authorization Holder

Nizhpharm JSC (Russia)

ATC Code

B02BC (Local hemostatics)

Active Substance

Sodium alginate (Ph.Eur. European Pharmacopoeia)

Dosage Form

Alginatol^®

Rectal suppositories for children 250 mg: 10 pcs.

Dosage Form, Packaging, and Composition

Rectal suppositories for children	1 supp.
Sodium alginate	250 mg

5 pcs. – contour cell packs (2) – cardboard packs.

Clinical-Pharmacological Group

Drug with hemostatic, anti-inflammatory, and wound-healing action for topical use in proctology

Pharmacotherapeutic Group

Topical hemostatic agent

Pharmacological Action

A hemostatic drug for topical use. It is a natural polysaccharide obtained from brown seaweed.

It has a pronounced hemostatic effect and possesses anti-inflammatory and reparative properties.

Indications

Anal fissures in the epithelialization stage
Chronic bleeding hemorrhoids
Proctosigmoiditis
Inflammation of the rectum in the postoperative period

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
K60	Fissure and fistula of anus and rectum
K62.8	Other specified diseases of anus and rectum (including proctitis)
K64	Hemorrhoids and perianal venous thrombosis

ICD-11 code	Indication
DB50.Z	Fissure or fistula of anal region, unspecified
DB6Z	Hemorrhoids or perianal venous diseases, unspecified
DB70.Z	Infections of anal and rectal regions, unspecified
DB72.Z	Some specified diseases of the anal canal, unspecified
DE2Z	Diseases of the digestive system, unspecified
EG61	Infections of the anus or perianal skin

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer one suppository rectally twice daily, typically in the morning and evening.

Continue treatment for a duration of 7 to 14 days, as determined by the prescribing physician based on the severity of the condition and the clinical response observed.

Adverse Reactions

Adverse reactions are infrequent and typically mild in nature.

The most commonly reported adverse reaction is localized allergic reactions, such as skin rash, itching, or redness at the application site. Discontinue use and seek medical advice if any signs of hypersensitivity appear.

Contraindications

Hypersensitivity to sodium alginate or any of the excipients contained in the suppository formulation.

Use in Pregnancy and Lactation

Rectal use during pregnancy and lactation is possible as indicated.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Rx Only

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer